Xiao-Xin Sun

Xiao-Xin Sun

Auto-generated profile, based on publicly available information

Xiao-Xin Sun

Department of Molecular & Medical Genetics, School of Medicine, Oregon Health & Science University, Portland, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
JLJuan Liu
Juan Liu
CZCen Zhang
Cen Zhang
HWHao Wu
Hao Wu
XSXiao-Xin Sun
Xiao-Xin Sun
YLYanchen Li
Yanchen Li
ZFZhaohui Feng
Zhaohui Feng
Phosphoglycerate dehydrogenase (PHGDH), the first rate-limiting enzyme of serine synthesis, is frequently overexpressed in human cancer. PHGDH overexpression activates serine synthesis to promote cancer progression. Currently, PHGDH regulation in normal cells and cancer is not well understood. Parkin, an E3 ubiquitin ligase involved in Parkinson’s disease, is a tumor suppressor. Parkin expression is frequently downregulated in many types of cancer, and its tumor-suppressive mechanism is poorly defined. Here, we show that PHGDH is a substrate for Parkin-mediated ubiquitination and degradation. Parkin interacted with PHGDH and ubiquitinated PHGDH at lysine 330, leading to PHGDH degradation to suppress serine synthesis. Parkin deficiency in cancer cells stabilized PHGDH and activated serine synthesis to promote cell proliferation and tumorigenesis, which was largely abolished by targeting PHGDH with RNA interference, CRISPR/Cas9 KO, or small-molecule PHGDH inhibitors. Furthermore, Parkin expression was inversely correlated with PHGDH expression in human breast cancer and lung cancer. Our results revealed PHGDH ubiquitination by Parkin as a crucial mechanism for PHGDH regulation that contributes to the tumor-suppressive function of Parkin and identified Parkin downregulation as a critical mechanism underlying PHGDH overexpression in cancer.

10 October 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XSXiao-Xin Sun
Xiao-Xin Sun
YCYingxiao Chen
Yingxiao Chen
YSYulong Su
Yulong Su
XWXiaoyan Wang
Xiaoyan Wang
KCKrishna Mohan Chauhan
Krishna Mohan Chauhan
MDMu-Shui Dai
Mu-Shui Dai
Significance: c-Myc is dynamically regulated by posttranslational modifications, including SUMOylation. However, how SUMOylation regulates c-Myc activity and stability remains elusive. In this study, we found that SENP1, a nuclear SUMO protease, deSUMOylates c-Myc, resulting in c-Myc stabilization and activation. We further show that c-Myc can be comodified by ubiquitination and SUMOylation and that this facilitates c-Myc targeting to the proteasome for degradation. DeSUMOylation of c-Myc by SENP1 suppressed c-Myc proteasome degradation and increased the level of transcriptionally active c-Myc, while knockdown of SENP1 reduced c-Myc levels and markedly suppressed cancer cell proliferation. We show that SENP1 is frequently overexpressed in human breast cancers. Thus, our study reveals SENP1 as a positive c-Myc regulator.

31 January 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
XCXiaowei Chen
Xiaowei Chen
MZMin Zhao
Min Zhao
JHJin Huang
Jin Huang
YLYuhuang Li
Yuhuang Li
SWShunqing Wang
Shunqing Wang
MDMu‐Shui Dai
Mu‐Shui Dai

18 February 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
XHXia He
Xia He
YLYuhuang Li
Yuhuang Li
MDMu-Shui Dai
Mu-Shui Dai
XSXiao-Xin Sun
Xiao-Xin Sun
Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop

13 March 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YCYingxiao Chen
Yingxiao Chen
YLYanping Li
Yanping Li
RDRoselyn S Dai
Roselyn S Dai
JSJonathan C Savage
Jonathan C Savage
USUjwal Shinde
Ujwal Shinde
MDMu-Shui Dai
Mu-Shui Dai
The RNA exosome is an essential 3′ to 5′ exoribonuclease complex that mediates degradation, processing and quality control of virtually all eukaryotic RNAs. The nucleolar RNA exosome, consisting of a nine-subunit core and a distributive 3′ to 5′ exonuclease EXOSC10, plays a critical role in processing and degrading nucleolar RNAs, including pre-rRNA. However, how the RNA exosome is regulated in the nucleolus is poorly understood. Here, we report that the nucleolar ubiquitin-specific protease USP36 is a novel regulator of the nucleolar RNA exosome. USP36 binds to the RNA exosome through direct interaction with EXOSC10 in the nucleolus. Interestingly, USP36 does not significantly regulate the levels of EXOSC10 and other tested exosome subunits. Instead, it mediates EXOSC10 SUMOylation at lysine (K) 583. Mutating K583 impaired the binding of EXOSC10 to pre-rRNAs, and the K583R mutant failed to rescue the defects in rRNA processing and cell growth inhibition caused by knockdown of endogenous EXOSC10. Furthermore, EXOSC10 SUMOylation is markedly reduced in cells in response to perturbation of ribosomal biogenesis. Together, these results suggest that USP36 acts as a SUMO ligase to promote EXOSC10 SUMOylation critical for the RNA exosome function in ribosome biogenesis.

12 August 2020 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
KCKrishna M. Chauhan
Krishna M. Chauhan
YCYingxiao Chen
Yingxiao Chen
YCYiyi Chen
Yiyi Chen
ALAndrew T. Liu
Andrew T. Liu
XSXiao‐Xin Sun
Xiao‐Xin Sun
MDMu‐Shui Dai
Mu‐Shui Dai